The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM), is excited to share that the Abstract Submission Application opens January 1, 20
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM), is excited to share that the Abstract Submission Application opens January 1, 20
Chemotherapy-induced peripheral neuropathy is linked to a decline in executive and neuromuscular function, new findings that may compromise mobility and increase fall risk.
Research presented at the 2023 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting emphasizes the potential need for patient support programs targeting at-risk populations to enhance disease management and reduce acute care utilization in myasthenia gravis.